David R. McAvoy - 04 Mar 2024 Form 4 Insider Report for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Role
EVP, Chief Legal Officer
Signature
/s/ Dov Bergwerk as attorney-in-fact for David R. McAvoy
Issuer symbol
TEVA
Transactions as of
04 Mar 2024
Net transactions value
$0
Form type
4
Filing time
05 Mar 2024, 16:46:42 UTC
Previous filing
04 Oct 2023
Next filing
06 Mar 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TEVA Restricted Share Units Award $0 +66,964 $0.000000 66,964 04 Mar 2024 Ordinary Shares 66,964 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
F2 Restricted share units were granted on March 4, 2024, with 16,741 vesting on each of March 4, 2025, March 4, 2026, March 4, 2027 and March 4, 2028.
F3 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.